Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
AbbVie to invest $380M in two new North Chicago plants for neuroscience and obesity drugs, launching in 2029 with 300 new jobs.
AbbVie will invest $380 million to build two new pharmaceutical manufacturing plants in North Chicago, using advanced technologies including artificial intelligence to produce active ingredients for neuroscience and obesity treatments.
Construction begins in spring 2026, with operations expected by 2029.
The project includes hiring 300 new employees and is part of a broader $100 billion U.S. investment commitment over the next decade, tied to a voluntary agreement with the Trump administration involving tariff exemptions and drug price reductions.
The expansion supports domestic manufacturing growth amid shifting trade policies.
AbbVie invertirá $ 380M en dos nuevas plantas del norte de Chicago para neurociencia y medicamentos para la obesidad, que se lanzarán en 2029 con 300 nuevos empleos.